Tysabri
OVERDOSE
Safety of doses higher than 300 mg has not been adequately evaluated. The maximum amount of TYSABRIÒ that can be safely administered has not been determined.
CONTRAINDICATIONS
TYSABRIÒ should not be administered to patients with known hypersensitivity to TYSABRIÒ or any of its components.
TYSABRIÒ is contraindicated in patients who have or have had progressive multifocal leukoencephalopathy (PML) (see BOXED WARNING and WARNINGS).
Generic Name: Natalizumab
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Multiple Sclerosis
Get the latest treatment options.
Yoga for MS
Yoga’s healing powers are now helping MS patients lead happier, healthier lives. See more WebMD Videos »
Tysabri
Health Resources
2008 Election & Health Care on WebMD. Get Informed.
Updated & New
RxList does not provide medical advice, diagnosis or treatment.